What is CaNCURE?

CaNCURE was created in 2015 to provide Northeastern University undergrads with experiential training in cancer nanomedicine.  Sixty-six trainees have already completed the program so far, and we expect to train another eighty-nine students in the next 5 years.
Our co-op students spend 6-months performing hands-on research in a NCI-funded research laboratory.   This research experience is supplemented with research and bio/nano innovation seminars, professional development activities, and opportunities to present research.
Our alumni have successfully found new co-op and jobs in cancer research, scholarships to medical school, and scholarships to graduate school.  58% of alumni are currently performing cancer research.

75

Trainees

29

Mentors

31

Publications

118

Presentations


Hear from our Alumni:

“CaNCURE presented me with so many opportunities to explore the world of medicine, both inside and outside of the lab. I am eternally grateful for the connections I have made through CaNCURE at DFCI. In fact, I consulted both my day-to-day mentor and my PI when deciding between offers for my second co-op cycle.”

Zoe Bishop, CaNCURE ’16


Trainee Spotlight


Kevin Lin

Health Science, '21

Granzyme B Peptide as a Non-invasive Theranostic Agent

Courtney Fraser

Health Science, '21

The Development and Characterization of Monoclonal Antibodies for Integrins and TGF-b

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Featured Trainee Publication


Upcoming Events

Check back soon for new events


Mentor Spotlight


Kenneth Anderson,

Physician of Oncology ,

Focuses on translational research in multiple myeloma. Students will have the opportunity to characterize factors in the marrow microenvironment which allow tumor cell homing, growth and resistance to apoptosis in the marrow millieu in order to identify and validate next-generation novel small molecule and immune targeted therapies.


Robert A Cormack, Ph.D.

Associate Professor of Radiation Oncology,

Our lab has shown that nanoparticles can enhance the effects of radiation therapy, thereby potentially improving patient outcomes. Students in this research group will explore ways to improve brachytherapy by developing new nanoparticle-based devices to enable minimally invasive means of delivering chemotherapeutic agents directly to tumors.


Trainee Spotlight


Mahimasri Kotamreddy

Biology and Mathematics, '21

Understanding the Role of Epigenetics in Multiple Myeloma Progression

Mia Wallach

Business (w Concentration in Healthcare Management and Consulting), '23

Nano-Talazoparib and Nano-Dinaciclib Combination Therapy for Lung Cancer Cells

Muskaan Rastogi

Health Science, '21

Monocyte Subtype Determination by Labeling with Feraheme Nanoparticles


 Get Involved

Interested in learning how nanomedicine is used to detect and treat cancer? Want to get involved in developing new nanotechnologies for the clinic? We are looking to match undergrads at Northeastern University with leading Boston researchers and clinicians for a six-month, hands-on research experience.  If you are thinking about a career in cancer science, engineering, or medicine, come get involved in the world’s first undergraduate program in cancer nanomedicine!  We have 9 upcoming openings for the January – June 2019 co-op period.  We will be accepting applications starting in September 2018 via NUcareers.

Going on in the lab right now...